Acitretin suppression of squamous cell carcinoma: Case report and literature review

Journal of Dermatological Treatment

Volumn 14, Issue SUPPL. 2, 2003, Pages 3-6

  Lebwohl, Mark ^a   Tannis, C ^a   Carrasco, D ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Acitretin; Psoriasis; PUVA; Retinoids; Squamous cell carcinoma

Indexed keywords

ETRETIN; METHOTREXATE; METHOXSALEN; RETINOID;

ADULT; ARTICLE; CARCINOGENESIS; CASE REPORT; CLINICAL FEATURE; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; HUMAN; LEG; MALE; PRIORITY JOURNAL; PSORIASIS; PUVA; RADIATION DOSE; SKIN CANCER; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME; ULTRAVIOLET B RADIATION;

EID: 0344309905     PISSN: 09546634     EISSN: None     Source Type: Journal    
DOI: 10.1080/738528792     Document Type: Article

References (22)

1. Lippman SM, Meyskens FL Jr, Treatment of advanced squamous cell carcinoma of the skin with isotretinoin. Ann Intern Med (1987) 107(4):499-502.
2. van de Kerkhof PC, de Rooij MJ, Multiple squamous cell carcinomas in a psoriatic patient following high-dose photochemotherapy and cyclosporine treatment: response to long-term acitretin maintenance. Br J Dermatol (1997) 136(2):275-8.
3. Braakhuis BJ, Klaassen I, van der Leede BM et al, Retinoid metabolism and all-trans retinoic acid-induced growth inhibition in head and neck squamous cell carcinoma cell lines. Br J Cancer (1997) 76(2):189-197.
4. D'Ambrosio SM, Gibson-D'Ambrosio R, Milo GE, Casto B, Kelloff GJ, Steele VE, Differential response of normal, premalignant and malignant human oral epithelial cells to growth inhibition by chemopreventive agents. Anticancer Res (2000) 20(4):2273-80.
5. Xu XC, Wong WY, Goldberg L et al, Progressive decreases in nuclear retinoid receptors during skin squamous carcinogenesis. Cancer Res (2001) 61(11):4306-10.
6. Sun SY, Wan H, Yue P, Hong WK, Lotan R, Evidence that retinoic acid receptor beta induction by retinoids is important for tumor cell growth inhibition. J Biol Chem (2000) 275(22):17149-53.
7. Sun SY, Yue P, Chandraratna RA, Tesfaigzi Y, Hong WK, Lotan R, Dual mechanisms of action of the retinoid CD437: nuclear retinoic acid receptor-mediated suppression of squamous differentiation and receptor-independent induction of apoptosis in UMSCC22B human head and neck squamous cell carcinoma cells. Mol Pharmacol (2000) 58(3):508-14.
8. Rudkin GH, Carlsen BT, Chung CY et al, Retinoids inhibit squamous cell carcinoma growth and intercellular communication. J Surg Res (2002) 103(2):183-9.
9. Hsu SL, Hsu JW, Liu MC, Chen LY, Chang CD, Retinoic acid-mediated G1 arrest is associated with induction of p27(Kip1) and inhibition of cyclin-dependent kinase 3 in human lung squamous carcinoma CH27 cells. Exp Cell Res (2000) 258(2):322-31.
10. Schoenermark MP, Mitchell TI, Rutter JL, Reczek PR, Brinckerhoff CE, Retinoid-mediated suppression of tumor invasion and matrix metalloproteinase synthesis. Ann N Y Acad Sci (1999) 878:466-86.
11. Liaudet-Coopman ED, Berchem GJ, Wellstein A, In vivo inhibition of angiogenesis and induction of apoptosis by retinoic acid in squamous cell carcinoma. Clin Cancer Res (1997) 3(2):179-84.
12. Rook AH, Jaworsky C, Nguyen T et al, Beneficial effect of low-dose systemic retinoid in combination with topical tretinoin for the treatment and prophylaxis of premalignant and malignant skin lesions in renal transplant recipients. Transplantation (1995) 59(5):714-19.
13. Kraemer KH, DiGiovanna JJ, Peck GL, Chemoprevention of skin cancer in xeroderma pigmentosum. J Dermatol (1992) 19(11):715-18.
14. George R, Weightman W, Russ GR, Bannister KM, Mathew TH, Acitretin for chemoprevention of non-melanoma skin cancers in renal transplant recipients. Australas J Dermatol (2002) 43(4):269-73.
15. Bouwes Bavinck JN, Tieben LM, Van der Woude FJ et al, Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal transplant recipients: a double-blind, placebo-controlled study. J Clin Oncol (1995) 13(8):1933-8.
16. Sanchez-Conejo-Mir J, Camacho F, Nevoid basal cell carcinoma syndrome: combined etretinate and surgical treatment. J Dermatol Surg Oncol (1989) 15(8):868-71.
17. Hughes BR, Marks R, Pearse AD, Gaskell SA, Clinical response tissue effects of etretinate treatment of patients with solar keratoses basal cell carcinoma. J Am Acad Dermatol (1988) 18(3):522-9.
18. Hodak E, Ginzburg A, David M, Sandbank M, Etretinate treatment of the nevoid basal cell carcinoma syndrome. Therapeutic and chemopreventive effect. Int J Dermatol (1987) 26(9):606-9.
19. Cristofolini M, Zumiani G, Scappini P, Piscioli F, Aromatic retinoid in the chemoprevention of the progression of nevoid basal-cell carcinoma syndrome. J Dermatol Surg Oncol (1984) 10(10):778-81.
20. Peck GL, Long-term retinoid therapy is needed for maintenance of cancer chemopreventive effect. Dermatologica 1987; 175(Suppl 1):138-44.
21. Yerebakan O, Ermis O, Yilmaz E, Basaran E, Treatment of arsenical keratosis and Bowen's disease with acitretin. Int J Dermatol (2002) 41(2):84-7.
22. EBPG Expert Group on Renal Transplantation, European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.6.2. Cancer risk after renal transplantation. Skin cancers: prevention and treatment. Nephrol Dial Transplant (2002) 17(Suppl 4):31-6.